Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.

Arthritis Res Ther · 2015 · PMC4660660 · PMID 26608564

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Association between circulating levels of TNC and measures of disease activity A cross-sectional correlation and univariate linear regression analysis between serum TNC levels and SLEDAI-2 K (β = 14, 95 % CI −1 to 29, r = 0.25, p = 0.061) and c-SLEDAI-2 K (β = 16, 95 % CI −0.7 to 33, r = 0.25, p = 0.060) at baseline visit showed a trend towards a positive correlation, although the results were not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.